Reportstack

Type 1 Diabetes (Juvenile Diabetes) - Pipeline Review, H2 2012 New Report

 

Naperville, IL -- (ReleaseWire) -- 10/04/2012 -- Type 1 Diabetes (Juvenile Diabetes) - Pipeline Review, H2 2012, provides an overview of the Type 1 Diabetes (Juvenile Diabetes) therapeutic pipeline. This report provides information on the therapeutic development for Type 1 Diabetes (Juvenile Diabetes), complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for Type 1 Diabetes (Juvenile Diabetes). 'Type 1 Diabetes (Juvenile Diabetes) - Pipeline Review, H2 2012' is built using data and information sourced from Global Markets Direct’s proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct’s team.

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

- A snapshot of the global therapeutic scenario for Type 1 Diabetes (Juvenile Diabetes).
- A review of the Type 1 Diabetes (Juvenile Diabetes) products under development by companies and universities/research institutes based on information derived from company and industry-specific sources.
- Coverage of products based on various stages of development ranging from discovery till registration stages.
- A feature on pipeline projects on the basis of monotherapy and combined therapeutics.
- Coverage of the Type 1 Diabetes (Juvenile Diabetes) pipeline on the basis of route of administration and molecule type.
- Profiles of late-stage pipeline products featuring sections on product description, mechanism of action and research & development progress.
- Key discontinued pipeline projects.
- Latest news and deals relating to the products.

Reasons to buy

- Identify and understand important and diverse types of therapeutics under development for Type 1 Diabetes (Juvenile Diabetes).
- Identify emerging players with potentially strong product portfolio and design effective counter-strategies to gain competitive advantage.
- Plan mergers and acquisitions effectively by identifying players with the most promising pipeline.
- Devise corrective measures for pipeline projects by understanding Type 1 Diabetes (Juvenile Diabetes) pipeline depth and focus of Type 1 Diabetes (Juvenile Diabetes) therapeutics.
- Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope.
- Modify the therapeutic portfolio by identifying discontinued projects and understanding the factors that drove them from pipeline.

Keywords

Type 1 Diabetes (Juvenile Diabetes) Therapeutic Products under Development, Key Players in Type 1 Diabetes (Juvenile Diabetes) Therapeutics, Type 1 Diabetes (Juvenile Diabetes) Pipeline Overview, Type 1 Diabetes (Juvenile Diabetes) Pipeline, Type 1 Diabetes (Juvenile Diabetes) Pipeline Assessment

To view table of contents for this market report please visit:
http://www.reportstack.com/product/90203/type-1-diabetes-juvenile-diabetes-pipeline-review-h2-2012.html